Ardelyx, Inc. - Common Stock (NQ:ARDX)

3.390 +0.360 (+11.88%)

Delayed Quote Updated: 9:31 AM EST, Nov 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ardelyx, Inc. - Common Stock

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 21, 2021

Gainers Chembio Diagnostics (NASDAQ: CEMI) shares rose 102.91% to $4.18 during Wednesday's pre-market session. The market value of their outstanding shares is at $84.6 million....

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

July 21, 2021

SVB Leerink boosted Intuitive Surgical, Inc. (NASDAQ: ISRG) price target from $930 to $975. Intuitive Surgical shares gained 3.8% to $991.17 in pre-market trading. Rosenblatt...

Via Benzinga

Scott+Scott Attorneys at Law LLP Announces Investigation into Ardelyx Inc. (ARDX)

July 20, 2021

From Scott+Scott Attorneys at Law LLP

Via Business Wire

Why Ardelyx Shares Tanked Today ↗

July 20, 2021

Ardelyx (NASDAQ: ARDX) shares are trading lower after the company received an FDA letter regarding its NDA for tenapanor indicating deficiencies that preclude discussion of...

Via Benzinga

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay ↗

July 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20) Alnylam Pharmaceuticals,...

Via Benzinga

Mid-Afternoon Market Update: Dow Jumps Over 600 Points; NeuroMetrix Shares Spike Higher ↗

July 20, 2021

Toward the end of trading Tuesday, the Dow traded up 1.83% to 34,583.56 while the NASDAQ rose 1.74% to 14,523.41. The S&P also rose, gaining 1.70% to 4,330.82. The U.S. has...

Via Benzinga

Topics Stocks

62 Biggest Movers From Yesterday ↗

July 21, 2021

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares surged 208% to settle at $10.04 on Tuesday as the company said it received FDA breakthrough device designation for the treatment...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 20, 2021

Gainers NeuroMetrix (NASDAQ:NURO) shares moved upwards by 177.6% to $9.05 during Tuesday's regular session. As of 12:30 EST, NeuroMetrix's stock is trading at a...

Via Benzinga

34 Stocks Moving In Tuesday's Mid-Day Session ↗

July 20, 2021

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares climbed 50.9% to $4.2550. NeuroMetrix, Inc. (NASDAQ: NURO) gained 37.4% to $4.4750 as the company said it received FDA...

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; Philip Morris Posts Mixed Q2 Results ↗

July 20, 2021

Following the market opening Tuesday, the Dow traded up 1.32% to 34,409.28 while the NASDAQ rose 0.48% to 14,343.85. The S&P also rose, gaining 0.91% to 4,297.39. The U.S. has...

Via Benzinga

Topics Stocks

ARDX Stock: Disastrous FDA News Sends Ardelyx Shares Plummeting ↗

July 20, 2021

News from the FDA is not good for ARDX stock. Investor reaction has been swift and harsh, as is often the case with risky biotech stocks.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Tuesday ↗

July 20, 2021

Before 10 a.m. ET Tuesday, 64 stocks made new 52-week lows. Key Facts: TotalEnergies (NYSE:TTE) was the largest, in terms of market cap, to set a new 52-week low....

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2021 ↗

July 20, 2021

Upgrades For Bank of Marin Bancorp (NASDAQ:

Via Benzinga

Why Ardelyx Stock Is Getting Crushed Today ↗

July 20, 2021

The FDA doesn't appear to be impressed by the biotech's experimental kidney disease drug.

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 20, 2021

Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) stock moved upwards by 36.87% to $3.86 during Tuesday's pre-market session. The market value of their outstanding shares...

Via Benzinga

24 Stocks Moving in Tuesday's Pre-Market Session ↗

July 20, 2021

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares rose 36.9% to $3.86 in pre-market trading after gaining more than 3% on Monday. SuperCom Ltd. (NASDAQ: SPCB) shares...

Via Benzinga

Ardelyx Stock Collapses After FDA Rejects Its Kidney Disease Candidate Pitch ↗

July 20, 2021

Three months after revealing that the FDA had asked for more information to support tenapanor application for a chronic kidney disease drug, the FDA issued a letter to ...

Via Benzinga

The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street ↗

July 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For July PDUFA Dates ↗

July 01, 2021

June was a month of plenty and also turned out to be a fruitful one from the perspective of Food and Drug Administration approvals. Regulatory reviews mostly produced positive...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 20, 2021

Gainers Enveric Biosciences (NASDAQ:ENVB)...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 30, 2021

Gainers Motus GI Hldgs (NASDAQ:MOTS) stock moved upwards by 30.17% to $1.42 during Friday's regular session. As of 12:31 EST, this security is trading at a volume of...

Via Benzinga

38 Stocks Moving In Friday's Mid-Day Session ↗

April 30, 2021

Gainers Image Sensing Systems, Inc. (NASDAQ: ISNS) rose 29.2% to $5.93 after the company announced it initiated a quarterly dividend of $0.12 per share, authorized a 220,000...

Via Benzinga

55 Biggest Movers From Friday ↗

May 03, 2021

Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) jumped 45.5% to close at $49.80 on Friday after dropping around 22% on Thursday. Brooklyn ImmunoTherapeutics acquired...

Via Benzinga

Why Ardelyx Stock Is Sinking Today ↗

April 30, 2021

The FDA pushed back its approval decision for the company's lead candidate.

Via The Motley Fool

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 30, 2021

Gainers Motus GI Hldgs (NASDAQ:MOTS) stock increased by 46.78% to $1.6 during Friday's pre-market session. The market value of their outstanding shares is at $74.7...

Via Benzinga

The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs ↗

April 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) AtriCure, Inc. (NASDAQ:...

Via Benzinga

22 Stocks Moving in Friday's Pre-Market Session ↗

April 30, 2021

Gainers Image Sensing Systems, Inc. (NASDAQ: ISNS) rose 30.7% to $6.00 in pre-market trading after the company announced it initiated a quarterly dividend of $0.12 per share,...

Via Benzinga

Ardelyx Stock Plummets As Review Period For Tenapanor US Application Pushed By 3 Months ↗

April 30, 2021

The FDA has extended the Prescription Drug User Fee Act (PDUFA) date for Ardelyx Inc's (NASDAQ: ARDX) tenapanor for the control of serum phosphorus...

Via Benzinga

15 Stocks Moving In Thursday's After-Hours Session ↗

April 29, 2021

Gainers Amazon (NASDAQ: AMZN) shares are trading higher after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q2 sales guidance above...

Via Benzinga

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.